Clinical trial
A Trial of Long-Acting Injectable Risperidone in the Treatment of…
NCT00284206 · Seattle Institute for Biomedical and Clinical Research, Other · Completed
Key facts
| NCT number | NCT00284206 |
|---|---|
| Title | A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence |
| Official title | An Open-Label Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence |
| Lead sponsor | Seattle Institute for Biomedical and Clinical Research, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Methamphetamine Dependence |
| Intervention type | Drug |
| Interventions | long-acting injectable risperidone |
| Enrollment | 20 |
| Start date | Jan 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 31, 2006 |
| Last update posted | Jan 11, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: